Online citations, reference lists, and bibliographies.
← Back to Search

Negative Autoregulation Of C‐myc Gene Expression Is Inactivated In Transformed Cells.

F. Grignani, L. Lombardi, G. Inghirami, L. Sternås, K. Cechova, R. Dalla‐Favera
Published 1990 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Negative feedback regulation of c‐myc gene expression has been observed in some, but not all, cell types. In order to demonstrate conclusively the existence of this mechanism and gain insight into the cause of its inactivation, we have directly examined its function in B cells and then investigated its activity in a number of cell types. We demonstrate the existence of negative c‐myc autoregulation by showing the rapid, dose dependent and reversible suppression of endogenous c‐myc expression in EBV‐immortalized B lymphoblastoid cells transfected with a c‐myc gene expressed under the control of a heavy metal inducible promoter. Autoregulation occurs at the level of transcriptional initiation and is mediated by at least one stable intermediate or cofactor molecule. The c‐myc autoregulatory mechanism was found operative in all (11 of 11) non‐tumorigenic cells tested, including normal and immortalized lymphocytes and fibroblasts. However, this mechanism was found to be inactive in all (10 of 10) tumor cell lines derived from a variety of tissues including those carrying normal and oncogenically activated c‐myc genes. These data establish the existence of an important regulatory circuit modulating c‐myc expression in normal cells and suggest that its inactivation may represent a general regulatory disturbance of transformed cells.



This paper is referenced by
10.1007/978-1-4615-1927-0
Normal and Malignant Hematopoiesis
E. Mihich (1995)
10.5772/54813
The MYCN Oncogene
L. Cheung (2013)
10.1016/0021-9150(92)90180-O
Hypercholesterolemia induces differential expression of rabbit apolipoprotein A and C genes.
P. Crespo (1992)
10.1158/0008-5472.CAN-12-2522
MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.
M. Kaur (2013)
10.1074/jbc.274.2.595
Mxi1 Is a Repressor of the c-myc Promoter and Reverses Activation by USF*
T. Lee (1999)
Acts via the PTEN Tumor Suppressor to Elicit Autoregulation and Genome-Wide Gene Repression by Activation of the Ezh 2 Methyltransferase
M. Kaur (2013)
10.1128/MCB.19.1.121
Spi-1/PU.1 Is a Positive Regulator of the Fli-1 Gene Involved in Inhibition of Erythroid Differentiation in Friend Erythroleukemic Cell Lines
J. Starck (1999)
10.1038/nrc2231
Reflecting on 25 years with MYC
N. Meyer (2008)
MODELLING, ANALYSIS AND DESIGN OF BIOELECTRONIC CIRCUITS IN VLSI
(2016)
10.1155/2014/757534
Mammalian MYC Proteins and Cancer
W. Tansey (2014)
10.4161/cc.6.22.4895
Feedback Regulation of c-Myc by Ribosomal Protein L11
M. Dai (2007)
10.1016/S0065-230X(08)60873-8
c-Myc in the control of cell proliferation and embryonic development.
J. M. Lemaître (1996)
Les lymphomes B diffus à grandes cellules de type activé : rôle de NF-κB et c-Myc.
N. Arnaud (2017)
10.1093/NAR/22.24.5151
An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1.
A. Shrivastava (1994)
10.1139/O92-143
Multiple antigens recognized by anti-c-myc antibodies in human cells and Xenopus oocytes.
A. Gibson (1992)
10.1096/fasebj.12.9.633
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
L. M. Facchini (1998)
10.1016/0005-2760(92)90260-3
Downregulation of hepatic albumin mRNA in response to induced hypercholesterolemia in rabbits.
P. Crespo (1992)
10.31274/RTD-180813-12890
Cadmium modification of cell growth and specific gene expression in normal rat-kidney fibroblast cells
N. Tang (1991)
10.1007/978-3-642-61180-3_13
Molecular Mechanisms Controlling Susceptibitliy to Tumor Necrosis Factor Induced Cell Death
J. Klefström (1996)
10.1007/BF00163964
Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements
L. T. Peltenburg (2004)
Effects of bifunctional chemotherapeutic agents on gene expression in the human tumor cell line Colo320HSR
Q. Dong (1993)
10.1101/GAD.4.12B.2235
New light on Myc and Myb. Part II. Myb.
B. Lüscher (1990)
10.1016/j.bbagrm.2014.05.016
Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
Daniel Diolaiti (2015)
Analysis of p53 and c-MYC, two key transcription factors involved in tumorigenesis
P. Jung (2008)
10.1038/sj.onc.1207225
Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product
Q. Luo (2004)
10.1182/BLOOD-2002-11-3387
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.
L. Pasqualucci (2003)
10.1371/journal.pone.0005076
Su(z)2 Antagonizes Auto-Repression of Myc in Drosophila, Increasing Myc Levels and Subsequent Trans-Activation
Abid Khan (2009)
10.1016/0022-1759(93)90004-Q
Generation of human monoclonal antibodies by transformation of lymphoblastoid B cells with ras oncogene.
S. Shammah (1993)
Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells.
M. Shichiri (1993)
10.1007/978-1-4615-1927-0_12
Advances in the Understanding of the Molecular Pathogenesis of Aggressive B Cell Lymphomas
K. Cechova (1995)
Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
A. Lerga (1999)
Initiation ofTranscription fromtheMinuteVirusofMiceP4 Promoter IsStimulated inRatCells Expressing a c-Ha-ras Oncogene
P. Spegelaere (1991)
See more
Semantic Scholar Logo Some data provided by SemanticScholar